1183 related articles for article (PubMed ID: 26844739)
21. The recognition and treatment of autoimmune epilepsy in children.
Suleiman J; Dale RC
Dev Med Child Neurol; 2015 May; 57(5):431-40. PubMed ID: 25483277
[TBL] [Abstract][Full Text] [Related]
22. [Limbic encephalitis--evolving concepts].
Serratrice G; Pellissier JF; Serratrice J; De Paula A
Bull Acad Natl Med; 2008 Nov; 192(8):1531-41; discussion 1541-2. PubMed ID: 19445370
[TBL] [Abstract][Full Text] [Related]
23. New-onset refractory status epilepticus: Etiology, clinical features, and outcome.
Gaspard N; Foreman BP; Alvarez V; Cabrera Kang C; Probasco JC; Jongeling AC; Meyers E; Espinera A; Haas KF; Schmitt SE; Gerard EE; Gofton T; Kaplan PW; Lee JW; Legros B; Szaflarski JP; Westover BM; LaRoche SM; Hirsch LJ;
Neurology; 2015 Nov; 85(18):1604-13. PubMed ID: 26296517
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
25. [Workup and treatment of autoimmune encephalitis].
Blaabjerg M; Mærsk-Møller CC; Kondziella D; Somnier F; Celicanin M; Andersen H; Bach FW; Pinborg LH
Ugeskr Laeger; 2015 Nov; 177(45):V05150448. PubMed ID: 26573937
[TBL] [Abstract][Full Text] [Related]
26. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry.
Marinas JE; Matveychuk D; Dursun SM; Baker GB
Acta Neuropsychiatr; 2020 Aug; 32(4):177-185. PubMed ID: 31791436
[TBL] [Abstract][Full Text] [Related]
27. [Recent changes in the paradigm of limbic encephalitis].
Illés Z
Ideggyogy Sz; 2011 Jul; 64(7-8):222-8. PubMed ID: 21863688
[TBL] [Abstract][Full Text] [Related]
28. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune encephalitis as differential diagnosis of infectious encephalitis.
Armangue T; Leypoldt F; Dalmau J
Curr Opin Neurol; 2014 Jun; 27(3):361-8. PubMed ID: 24792345
[TBL] [Abstract][Full Text] [Related]
30. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
[TBL] [Abstract][Full Text] [Related]
31. What should you know about limbic encephalitis?
Machado S; Pinto AN; Irani SR
Arq Neuropsiquiatr; 2012 Oct; 70(10):817-22. PubMed ID: 23060110
[TBL] [Abstract][Full Text] [Related]
32. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune Encephalopathies and Dementias.
McKeon A
Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):538-58. PubMed ID: 27042907
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
35. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
36. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
Casault C; Alikhani K; Pillay N; Koch M
J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
[TBL] [Abstract][Full Text] [Related]
37. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
38. Limbic encephalitis and variants: classification, diagnosis and treatment.
Tüzün E; Dalmau J
Neurologist; 2007 Sep; 13(5):261-71. PubMed ID: 17848866
[TBL] [Abstract][Full Text] [Related]
39. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report.
Gagnon MM; Savard M; Mourabit Amari K
Seizure; 2016 Apr; 37():25-7. PubMed ID: 26921483
[TBL] [Abstract][Full Text] [Related]
40. [Autoimmune Associated Encephalitis and Dementia].
Watanabe O
Brain Nerve; 2016 Apr; 68(4):341-50. PubMed ID: 27056852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
